Skip to content

A study on the clinical efficacy and near-infrared brain function mechanism of MRI-guided rTMS combined with rPMS in patients with Parkinson's disease

A study on the clinical efficacy and near-infrared brain function mechanism of MRI-guided rTMS combined with rPMS in patients with Parkinson's disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128764
Enrollment
Unknown
Registered
2026-07-24
Start date
2025-11-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

rTMS+rPMS group:Bilateral M1 area rTMS combined with rPMS high-frequency stimulation
rTMS group:Bilateral M1 region rTMS high-frequency stimulation

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 45-80 years; 2. Meet the 2015 MDS diagnostic criteria for Parkinson's disease; 3. Hoehn-Yahr stage (H-Y stage): 1-4; 4. Have one or more of the following conditions: one or more types of PD pain with a Numerical Rating Scale (NRS) score >= 3; one or more types of sleep disorders; freezing of gait;balance disorders;swallowing dysfunction. 5. Mini-Mental State Examination (MMSE) score >= 22; 6. Have been taking PD medication stably for more than 2 weeks and the medication regimen will not be changed during the study; 7. Patients provide informed consent.

Exclusion criteria

Exclusion criteria: 1. The subject experiences an intolerable adverse event (AE), and the subject and/or the investigator determine that the AE cannot be controlled by appropriate treatment; 2. The subject receives treatment that is not allowed in this study, such as pacemaker, DBS, cochlear implant and other metal implants; 3. The subject develops suicidal tendencies or psychotic symptoms; 4. The subject's pain is caused by other clear causes (such as osteoarthritis, diabetic neuropathy, tumors, etc.); 5. The subject develops severe neurological/psychiatric diseases such as impaired consciousness, cerebral hemorrhage, cerebral thrombosis and other serious organic diseases; 6. There are other diseases that may affect peripheral nerve sensation, including diabetes, herpes infection, long-term special drugs or alcoholism, stroke, spinal cord lesions; 7. The subject fails to fully comply with the study procedures.

Design outcomes

Primary

MeasureTime frame
Motor symptom;

Secondary

MeasureTime frame
non-motor symptom;fNIRS;

Countries

China

Contacts

Public ContactDong Liguo

The Affiliated Hospital of Xuzhou Medical University

ilmldlg@163.com+86 516 85802275

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026